Our results, together with evidence from other studies indicate a role of Cyp46A1 in aberrant brain cholesterol metabolism in neurodegenerative diseases and that it would be a valuable and novel drug target in prion diseases. The gene discussed is CYP46A1; the disease is neurodegenerative disease.